Sources: Population data - United Nations, Population Division, The World Population Prospects - the 2008 revision,
New York, 2009; Population requiring PC for STH - STH: estimates of the number of children needing preventive
chemotherapy and number treated, 2009. WER, N°25, 2011, 86:257–268. Population requiring PC for LF - PELF;
Population requiring PC for SCH - estimates based on L.Chitsulo et al. / Acta Tropica 77(2000)41-51; Population
requiring PC for Oncho - APOC; Population requiring PC for Trachoma - GET2020; School enrolment data - UNESCO
Institute of Statistics, 2000 Assessment.
1 United Nations classification; 2 World Bank classification.
2
CO
UN
TR
Y P
RO
FIL
EP
RE
VE
NTI
VE
CH
EM
OTH
ER
AP
Y A
ND
TR
AN
SM
ISS
ION
CO
NTR
OL
D
EPA
RTM
EN
T O
F C
ON
TRO
L O
F N
EG
LEC
TED
TR
OP
ICA
L D
ISE
AS
ES
2010COTE D’IVOIRE
Maps of infection/disease endemicity
Ghana
Guinea
Liberia
MaliBurkina Faso
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ' WHO 2008. All rights reserved
4
Endemicity of LFNon-endemic
Endemic
Uncertain
Lymphatic filariasis
0 90 180 270 36045
Kilometers
Ghana
Guinea
Liberia
MaliBurkina Faso
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ' WHO 2008. All rights reserved
4
Endemicity of OnchoNon-endemic
Endemic
Onchocerciasis
0 90 180 270 36045
Kilometers
Ghana
Guinea
Liberia
MaliBurkina Faso
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ' WHO 2008. All rights reserved
4
Prevalence of SCH_hNo data
Less than 10%
>=10% and <50%
50% and above
Schistosomiasis, S. haematobium
0 90 180 270 36045
Kilometers
Ghana
Guinea
Liberia
MaliBurkina Faso
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ' WHO 2008. All rights reserved
4
Prevalence of SCH_mNo data
Less than 10%
>=10% and <50%
50% and above
Schistosomiasis, S. mansoni
0 90 180 270 36045
Kilometers
Ghana
Guinea
Liberia
MaliBurkina Faso
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ' WHO 2008. All rights reserved
4
Prevalence of STHNo data
Less than 20%
>=20% and <50%
50% and above
Soil-transmitted helminthiasis
0 90 180 270 36045
Kilometers
Ghana
Guinea
Liberia
MaliBurkina Faso
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ' WHO 2010. All rights reserved
4
TFUnknown
Active trachoma (TF, 1-9 years old)
0 90 180 270 36045
Kilometers
3
CO
UN
TR
Y PR
OF
ILE
PR
EV
EN
TIVE
CH
EM
OTH
ER
AP
Y A
ND
TRA
NS
MIS
SIO
N C
ON
TRO
L D
EPA
RTM
EN
T OF C
ON
TRO
L OF N
EG
LEC
TED
TRO
PIC
AL D
ISE
AS
ES
2010COTE D’IVOIRE
Maps of preventive chemotherapy strategy required
MDA1 (IVM+ALB), MDA2 (DEC+ALB), MDA3 (IVM), T1 (ALB or MBD + PZQ), T2 (PZQ), T3 (ALB or MBD)
Ghana
Guinea
Liberia
MaliBurkina Faso
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ' WHO 2008. All rights reserved
4
ROUND 1No implementation
MDA1
MDA3
T3
PC strategy required - ROUND 1
0 90 180 270 36045
Kilometers
Ghana
Guinea
Liberia
MaliBurkina Faso
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ' WHO 2008. All rights reserved
4
ROUND 2No impl./No data
T1
T2
T2 once in two years
T3
PC strategy required - ROUND 2
0 90 180 270 36045
Kilometers
4
CO
UN
TR
Y P
RO
FIL
EP
RE
VE
NTI
VE
CH
EM
OTH
ER
AP
Y A
ND
TR
AN
SM
ISS
ION
CO
NTR
OL
D
EPA
RTM
EN
T O
F C
ON
TRO
L O
F N
EG
LEC
TED
TR
OP
ICA
L D
ISE
AS
ES
2010COTE D’IVOIRE
Preventive chemotherapy implementation
PREVENTIVE CHEMOTHERAPY IMPLEMENTATION
MDA1 (IVM + ALB)Population targeted
Population treated
Geographical coverage
Programme coverage
MDA2 (DEC + ALB)Population targeted
Population treated
Geographical coverage
Programme coverage
MDA3 (IVM)Population targeted
Population treated
Geographical coverage
Programme coverage
T1 (ALB or MBD + PZQ)Population targeted
Population treated
Geographical coverage
Programme coverage
T2 (PZQ)Population targeted
Population treated
Geographical coverage
Programme coverage
T3 (ALB or MBD)Population targeted
Population treated
Geographical coverage
Programme coverage
A (AZI)Population targeted
Population treated
Geographical coverage
Programme coverage
T1 (ALB or MBD + PZQ)Population targeted
Population treated
Geographical coverage
Programme coverage
T2 (PZQ)Population targeted
Population treated
Geographical coverage
Programme coverage
T3 (ALB or MBD)Population targeted
Population treated
Geographical coverage
Programme coverage
2009
1,159,593
914,720
9.4%
78.9%
PreSAC/SAC
10,143,524
SAC
12,722
2008
2,039,000
404,397
27.3%
19.8%
PreSAC/SAC
3,377,397
2007
SAC
374,923
2006 2010
7,808,346
2,458,436
40.6%
31.5%
SAC
2,305,813
RO
UN
D 1
RO
UN
D 2
Geographical coverage - proportion (%) of endemic districts covered with preventive chemotherapy;Programme coverage - proportion (%) of individuals who were treated as per the programme target.
5
CO
UN
TR
Y PR
OF
ILE
PR
EV
EN
TIVE
CH
EM
OTH
ER
AP
Y A
ND
TRA
NS
MIS
SIO
N C
ON
TRO
L D
EPA
RTM
EN
T OF C
ON
TRO
L OF N
EG
LEC
TED
TRO
PIC
AL D
ISE
AS
ES
2010COTE D’IVOIRE
National disease-specific coverage
Pre-SAC ** SAC
LYMPHATIC FILARIASIS SCHISTOSOMIASIS *
SOIL-TRANSMITTED HELMINTHIASIS
ONCHOCERCIASIS ***
0
1
2
3
4
2005 2006 2007 2008 2009 2010
Mill
ions
0%
20%
40%
60%
80%
100%
Requiring PCTreatedNational coverage
0
1
2
3
4
5
6
7
2005 2006 2007 2008 2009 2010
0%
20%
40%
60%
80%
100%
Requiring PCTreatedNational coverage
National disease-specific coverage - proportion (%) of individuals in the population requiring preventivechemotherapy for the specific disease (see Basic country data on page 1) that have been treated.
0.0
0.5
1.0
1.5
2.0
2.5
2008
Mill
ions
0%
5%
10%
15%
20%
25%
Requiring PCTreatedNational coverage
TRACHOMA
No data available
** Number of individuals received at least one round of annual treatment.
0
4
8
12
16
2009 2010
Mill
ions
0%
5%
10%
15%
20%
Requiring PCTreatedNational coverage
0
2
4
6
2009
Mill
ions
0.0%
0.1%
0.1%
0.2%
0.2%
0.3%
Requiring PCTreatedNational coverage
* SAC
*** Number of people treated via LF programme (MDA1) is not included in this chart.
6
CO
UN
TR
Y P
RO
FIL
EP
RE
VE
NTI
VE
CH
EM
OTH
ER
AP
Y A
ND
TR
AN
SM
ISS
ION
CO
NTR
OL
D
EPA
RTM
EN
T O
F C
ON
TRO
L O
F N
EG
LEC
TED
TR
OP
ICA
L D
ISE
AS
ES
2010COTE D’IVOIRE
Monitoring decline of disease endemicity(in sentinel sites or periodic surveys)
LYMPHATIC FILARIASIS
Cumulative number of SS with base line mf>1% identified
(of total)
Percent of the SS (with a baseline of >1%) which have
Mf prev <1% in year
No. of IUs where MDA discontinued after meeting
epidemiological criteria
Years ->
Data source:
SOIL-TRANSMITTED HELMINTHIASIS
Years ->
STH prevalence in pre-SAC (range)
STH prevalence in SAC (range)
Data source:
SCHISTOSOMIASIS
Years ->
S. haematobium prevalence (range)
S. mansoni prevalence (range)
Data source:
ONCHOCERCIASIS
Years ->
Number of endemic communities
Number of endemic communities with baseline >1%
Number of endemic communities discontinued after
meeting epidemiological criteria
Data source:
For more detailed information, please contact:
Preventive Chemotherapy and Transmission Control, Department of Control of Neglected Tropical DiseasesWorld Health Organization, 20, avenue Appia, 1211 Geneva 27, Switzerland
We would also like to be informed as soon as possible if we have made any errors in detailing your activities orif you have any other comments. Thank you for your collaboration.
